Please use this identifier to cite or link to this item: https://hdl.handle.net/10923/11627
Type: Article
Title: Cost of preventing an event (COPE) of enzalutamide versus abiraterone plus prednisone in men with metastatic castration-resistant prostate cancer under the Brazilian private health care system perspective
Author(s): Stephen Doral Stefani
Vanessa Teich
André Poisl Fay
Marcia Abadi
Scott Flanders
Cat Bui
Andre Sasse
In: Jornal Brasileiro de Economia da Saúde
Issue Date: 2015
Volume: 7
Issue: 3
First page: 127
URI: http://hdl.handle.net/10923/11627
ISSN: 2175-2095
Appears in Collections:Artigo de Periódico



All Items in PUCRS Repository are protected by copyright, with all rights reserved, and are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Read more.